BlackRock
XAGE

BlackRock’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

BlackRock’s Portfolio XAGE Stock Details XAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,054
Closed -$2.66K – 5633
2025
Q2 		$2.66K Sell
1,054
-1,037
-50% -$3.79K ﹤0.01% 5311
2025
Q1 		$7.85K Sell
2,091
-21
-1% -$204 ﹤0.01% 5198
2024
Q4 		$17.7K Buy
2,112
+7
+0.3% +$67 ﹤0.01% 5119
2024
Q3 		$25.4K Buy
2,105
+894
+74% +$24.4K ﹤0.01% 4908
2024
Q2 		$48.3K Buy
1,211
+158
+15% +$10.4K ﹤0.01% 4867
2024
Q1 		$80.9K Hold
1,053
– – ﹤0.01% 4781
2023
Q4 		$120K Hold
1,053
– – ﹤0.01% 4759
2023
Q3 		$114K Buy
+1,053
New +$159K ﹤0.01% 4807

Other funds holding XAGE

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
CMU
Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return

BlackRock's XAGE Position: Q3 2025 in Review

BlackRock sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2025, closing a stake of 1,054 shares — an estimated $2.66K sold.

BlackRock first reported a position in XAGE in Q3 2023 and held it in 8 quarters. The position peaked at $120K in Q4 2023. 3 funds tracked by Wall St. Rank hold XAGE as of Q3 2025.

  • BlackRock reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
  • BlackRock sold 1,054 Longevity Health Holdings, Inc. Common Stock shares in Q3 2025, an estimated $2.66K.
  • BlackRock first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2023 and held it in 8 quarters.
  • BlackRock's Longevity Health Holdings, Inc. Common Stock position peaked at $120K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2025.

Based on BlackRock's 13F filing for Q3 2025, filed 12 Nov 2025.